Metformin was introduced as a medication in 1957, and was recommended by the ADA and EASD in their joint position statement in 2012 and 2015 as initial monotherapy, unless there is intolerance or contraindication. What is your overall opinion of metformin as the initial first-line drug in patients with type 2